No Data
No Data
Centessa Pharmaceuticals Price Target Announced at $14.00/Share by Oppenheimer
Centessa Pharmaceuticals Price Target Announced at $14.00/Share by
Centessa Pharmaceuticals Initiated at Outperform by Oppenheimer
Centessa Pharmaceuticals Initiated at Outperform by
Oppenheimer Initiates Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Announces Target Price $14
Oppenheimer analyst Francois Brisebois initiates coverage on $Centessa Pharmaceuticals(CNTA.US)$ with a buy rating, and sets the target price at $14.According to TipRanks data, the analyst has a
Express News | Centessa Pharmaceuticals PLC : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $14
Oppenheimer Initiates Centessa Pharmaceuticals at Outperform Rating With $14 Price Target
Centessa Pharmaceuticals (CNTA) has an average buy rating and a price target range of $11 to $20, according to analysts polled by Capital IQ.
Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Jaguar8 : A big ouch
TrytosaveabitOP Jaguar8: Not as bad as I thought!
Jaguar8 TrytosaveabitOP: CYN was bad haha
TrytosaveabitOP Jaguar8: Yes it was! Hehehe
Jaguar8 TrytosaveabitOP: I’m sure a lot got caught off guard and end up bagholding. Scaling out is key
View more comments...